Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Option Care Health Inc (OPCH)

Option Care Health Inc (OPCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,756,664
  • Shares Outstanding, K 173,498
  • Annual Sales, $ 4,302 M
  • Annual Income, $ 267,090 K
  • 60-Month Beta 1.21
  • Price/Sales 1.32
  • Price/Cash Flow 17.37
  • Price/Book 4.08
Trade OPCH with:

Options Overview Details

View History
  • Implied Volatility 39.61% ( +5.53%)
  • Historical Volatility 28.06%
  • IV Percentile 65%
  • IV Rank 40.13%
  • IV High 76.92% on 06/15/23
  • IV Low 14.60% on 12/11/23
  • Put/Call Vol Ratio 0.01
  • Today's Volume 221
  • Volume Avg (30-Day) 361
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 11,420
  • Open Int (30-Day) 10,821

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.23
  • Number of Estimates 7
  • High Estimate 0.25
  • Low Estimate 0.19
  • Prior Year 0.21
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.87 +8.65%
on 03/15/24
34.17 -1.84%
on 03/28/24
+1.93 (+6.11%)
since 02/28/24
3-Month
30.74 +9.11%
on 01/29/24
34.63 -3.13%
on 02/22/24
-0.48 (-1.41%)
since 12/28/23
52-Week
24.23 +38.42%
on 05/04/23
35.74 -6.16%
on 08/16/23
+1.89 (+5.97%)
since 03/28/23

Most Recent Stories

More News
Why Is Wall Street So Bullish About These 2 Russell 2000 Stocks?

These high-quality, small-cap growth stocks can help generate robust returns in the coming years.

$SPX : 5,254.35 (+0.11%)
$NASX : 16,379.46 (-0.12%)
CELH : 82.92 (-0.61%)
MNST : 59.28 (+0.14%)
OPCH : 33.54 (+1.08%)
PEP : 175.01 (+0.83%)
PLTR : 23.01 (-6.12%)
3 Reasons Palantir Stock Can Double Again in 2024

Palantir stock soared 167% last year. It could repeat the feat.

PLTR : 23.01 (-6.12%)
OPCH : 33.54 (+1.08%)
Why Option Care Health Stock Plummeted Today

Option Care Health fell despite posting strong quarterly results. Here's what investors need to know.

OPCH : 33.54 (+1.08%)
Option Care Health Confirms Termination of Merger Agreement with Amedisys

/PRNewswire/ -- Option Care Health, Inc. ("Option Care Health" or the "Company") (Nasdaq: OPCH) today announced that it has terminated its previously announced...

OPCH : 33.54 (+1.08%)
Option Care Health Reiterates Value Creation Opportunity of its Previously Announced Definitive Merger Agreement with Amedisys

/PRNewswire/ -- Option Care Health, Inc. ("Option Care Health") (Nasdaq: OPCH) today filed with the U.S. Securities and Exchange Commission a registration...

OPCH : 33.54 (+1.08%)
AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amedisys, Inc. (NasdaqGS: AMED) to Option Care...

AMED : 92.16 (-0.32%)
OPCH : 33.54 (+1.08%)
ALERT: Rowley Law PLLC is Investigating Proposed Merger of Amedisys, Inc.

/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Amedisys, Inc. (NASDAQ: AMED) and its board of directors concerning the...

AMED : 92.16 (-0.32%)
OPCH : 33.54 (+1.08%)
Markets Today: Stock Index Futures Lower on Bank Jitters and ECB Rate Hike

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are down -0.30%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.12%. U.S. stock index futures this morning are moderately lower....

ESM24 : 5,308.50s (unch)
NQM24 : 18,475.00s (-0.16%)
PACW : 7.54 (-2.71%)
WAL : 64.19 (-0.05%)
ZION : 43.40 (+0.58%)
TFC : 38.98 (+1.01%)
CMA : 54.99 (+1.40%)
KEY : 15.81 (+1.09%)
QCOM : 169.30 (+0.10%)
TRIP : 27.79 (-0.22%)
OPCH : 33.54 (+1.08%)
FHN : 15.40 (+0.52%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RUTH, MGTA, OPCH, AMED

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RUTH : 21.49 (+0.05%)
MGTA : 11.1936 (-7.74%)
OPCH : 33.54 (+1.08%)
AMED : 92.16 (-0.32%)
OPCH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Option Care Health, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Option Care Health, Inc. (NASDAQ: OPCH) and Amedisys, Inc. is fair to Option Care shareholders. Upon completion of...

OPCH : 33.54 (+1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Option Care Health Inc provides infusion and home care management solutions. The Company offers products, services and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders and heart failures....

See More

Key Turning Points

3rd Resistance Point 35.06
2nd Resistance Point 34.61
1st Resistance Point 34.08
Last Price 33.54
1st Support Level 33.10
2nd Support Level 32.65
3rd Support Level 32.12

See More

52-Week High 35.74
Last Price 33.54
Fibonacci 61.8% 31.34
Fibonacci 50% 29.99
Fibonacci 38.2% 28.63
52-Week Low 24.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar